Ultraproct (suppositories and ointment): Supply issue
Because of delays at the factory where Ultraproct is made, these products are now out of stock.
27 March 2026 | Resupply now late 2026
Because of a change in manufacturing site, the supplier advises that it expects Ultraproct to be available later in 2026.
Both suppositories and ointment are out of stock
Because of a delays at the factory where Ultraproct is made, will not be available again before late 2026.
The active ingredients in Ultraproct are fluocortolone caproate with fluocortolone pivalate and cinchocaine.
Schedule listing for Ultraproct(external link)
Alternative product available: Proctosedyl
We have received clinical advice that Proctosedyl may a suitable funded alternative. It is available as an ointment, unfortunately the suppository is out of stock, however we have listed an alternative, Scheriproct.
People who cannot access Ultraproct will need a new prescription. Proctosedyl and Scheriproct have different active ingredients.
Schedule listings for anti-haemorrhoidal treatments(external link)
Flier for pharmacists to support conversations with affected people
- General Supply Issue A5 Flier [PDF 111 KB]
Expected resupply
Resupply is expected by the late 2026.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, Pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)